Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Sees Large Decrease in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large drop in short interest in March. As of March 31st, there was short interest totalling 32,500 shares, a drop of 57.6% from the March 15th total of 76,600 shares. Based on an average daily volume of 447,500 shares, the days-to-cover ratio is presently 0.1 days.

Ono Pharmaceutical Trading Up 4.8 %

Shares of OPHLY traded up $0.19 during midday trading on Friday, hitting $4.15. The company’s stock had a trading volume of 166,344 shares, compared to its average volume of 427,249. Ono Pharmaceutical has a one year low of $3.21 and a one year high of $5.20. The company’s fifty day simple moving average is $3.64 and its two-hundred day simple moving average is $3.74.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.